Cepheid (CPHD.O)
14.99USD
9 Feb 2010
$0.28 (+1.90%)
$14.99
--
$15.14
$14.68
273,718
495,288
$16.47
$4.93
CPHD.O
About
Overall
| Beta: | 1.33 |
| Market Cap (Mil.): | $878.24 |
| Shares Outstanding (Mil.): | 58.59 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| CPHD.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 6.39 | 3.76 |
| EPS (TTM): | 0.96 | -- | -- |
| ROI: | -16.73 | 1.18 | 2.30 |
| ROE: | -17.55 | 1.76 | 2.82 |
UPDATE 1-Cepheid posts narrower quarterly loss
Jan 28 (Reuters) - Molecular diagnostics company Cepheid posted a narrower-than-expected quarterly loss as revenue jumped 30 percent but forcast a weak 2010.
UPDATE 1-Cepheid gets FDA emergency approval for H1N1 assay
* Co to continue development of expanded influenza panel test
UPDATE 1-Cepheid's thrombosis test gets FDA nod
* Says test to be marketed with Instrumentation Laboratory
HEADLINE STOCKS-Some U.S. stocks on the move on Sept. 9
(Updates to afternoon trading; adds DuPont, Barrick, K12, Ista, UPS, Starbucks, Fortress, Juniper, Genworth, Palm, Cepheid, eBay, MSC Software)
UPDATE 1-Cepheid to accelerate development of Flu A panel test
Sept 9 (Reuters) - Cepheid said it is accelerating development a Flu A Panel test, which will discriminate among the multiple influenza strains, and the test is expected to be authorized for use during the upcoming influenza season, with product shipments beginning in January 2010.
HEADLINE STOCKS-Some U.S. stocks on the move on July 13
(Updates to after the open, adds J&J, Google , Cincinnati Financial, Cardionet and Cepheid. Updates BofA.)
UPDATE 1-Cepheid gets FDA nod for bacterial infection test
July 13 (Reuters) - Cepheid Inc said the U.S. health regulator granted marketing approval for the company's diagnostic test to detect a possibly fatal bacterial infection, sending its shares up 8 percent.
HEADLINE STOCKS-U.S. stocks on the move on April 24
NEW YORK, April 24 (Reuters) - Some U.S. stocks on the move on Friday:
HEADLINE STOCKS-U.S. stocks on the move on April 24
NEW YORK, April 24 (Reuters) - Some U.S. stocks on the move
HEADLINE STOCKS-U.S. stocks on the move on April 24
NEW YORK, April 24 (Reuters) - Some U.S. stocks on the move
Competitors
| Price | Change | |
|---|---|---|
| Life Technologies Corp. (LIFE.OQ) | $47.82 | +0.40 |
| Roche Holding Ltd. (ROG.VX) | CHF176.60 | +0.50 |
| Abbott Laboratories (ABT.N) | $53.35 | 0.00 |
| Becton, Dickinson and Co. (BDX.N) | $75.26 | +0.58 |
| Qiagen NV (QGEN.OQ) | $20.60 | -0.06 |
| Celera Corporation (CRA.OQ) | $6.58 | +0.36 |
| Siemens AG (SIEGn.DE) | €63.60 | +0.62 |
| Hologic, Inc. (HOLX.OQ) | $16.03 | +0.03 |
| BioMerieux SA (BIOX.PA) | €78.15 | +0.80 |
| Beckman Coulter, Inc. (BEC.N) | $64.07 | -0.07 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
